| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
LGND Technical Analysis
5
| As on 9th Jun 2023 LGND SHARE Price closed @ 73.76 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 99.88 & Strong Sell for SHORT-TERM with Stoploss of 124.50 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LGNDSHARE Price
| Open | 74.50 | Change | Price | % |
| High | 74.87 | 1 Day | -0.52 | -0.70 |
| Low | 73.40 | 1 Week | 3.68 | 5.25 |
| Close | 73.76 | 1 Month | -3.50 | -4.53 |
| Volume | 114030 | 1 Year | -77.26 | -51.16 |
| 52 Week High 162.86 | 52 Week Low 62.00 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| LGND Daily Charts |
LGND Intraday Charts |
Whats New @ Bazaartrend |
LGND Free Analysis |
|
|
LGND Important Levels Intraday
| RESISTANCE | 76.59 |
| RESISTANCE | 75.68 |
| RESISTANCE | 75.12 |
| RESISTANCE | 74.56 |
| SUPPORT | 72.96 |
| SUPPORT | 72.40 |
| SUPPORT | 71.84 |
| SUPPORT | 70.93 |
LGND Forecast April 2024
| 4th UP Forecast | 147.41 |
| 3rd UP Forecast | 123.79 |
| 2nd UP Forecast | 109.19 |
| 1st UP Forecast | 94.59 |
| 1st DOWN Forecast | 52.93 |
| 2nd DOWN Forecast | 38.33 |
| 3rd DOWN Forecast | 23.73 |
| 4th DOWN Forecast | 0.11 |
LGND Weekly Forecast
| 4th UP Forecast | 105.38 |
| 3rd UP Forecast | 95.24 |
| 2nd UP Forecast | 88.97 |
| 1st UP Forecast | 82.70 |
| 1st DOWN Forecast | 64.82 |
| 2nd DOWN Forecast | 58.55 |
| 3rd DOWN Forecast | 52.28 |
| 4th DOWN Forecast | 42.14 |
LGND Forecast2024
| 4th UP Forecast | 280.08 |
| 3rd UP Forecast | 213.91 |
| 2nd UP Forecast | 173.01 |
| 1st UP Forecast | 132.11 |
| 1st DOWN Forecast | 15.41 |
| 2nd DOWN Forecast | -25.49 |
| 3rd DOWN Forecast | -66.39 |
| 4th DOWN Forecast | -132.56 |
Ligand Pharmaceuticals Incorporated ( NASDAQ USA Symbol : LGND )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LGND Business Profile
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company's commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for the treatment of osteoporosis; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of PPD; Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney, and other diseases. In addition, the company is involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated was founded in 1987 and is headquartered in Emeryville, California. Address: 5980 Horton Street, EmeryVille, CA, United States, 94608
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service